Form 8-K - Current report:
SEC Accession No. 0001564590-19-044001
Filing Date
2019-11-21
Accepted
2019-11-20 19:20:53
Documents
1
Period of Report
2019-11-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K arwr-8k_20191115.htm 8-K 28675
  Complete submission text file 0001564590-19-044001.txt   30161
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 191235390
SIC: 2834 Pharmaceutical Preparations